S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Did you mean NF2 as a gene symbol? Search ClinVar for NF2

See NF2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor in the Gene database

Search results

Items: 1 to 100 of 986

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review statusAccession
1.
GRCh37:
Chr22:29996311-29999991
GRCh38:
Chr22:29600322-29604002
NF2Neurofibromatosis, type 2Pathogenic
(Nov 27, 2019)
criteria provided, single submitterVCV000967709
2.
GRCh37:
Chr22:29998464-30035142
GRCh38:
Chr22:29602475-29639153
NF2See casesPathogenic
(May 6, 2011)
no assertion criteria providedVCV000148402
3.
GRCh37:
Chr22:29999236
GRCh38:
Chr22:29603247
NF2not providedBenign
(Jun 14, 2018)
criteria provided, single submitterVCV000683799
4.
GRCh37:
Chr22:29999343-29999344
GRCh38:
Chr22:29603354-29603355
NF2not providedBenign
(May 22, 2021)
criteria provided, single submitterVCV001282056
5.
GRCh37:
Chr22:29999344
GRCh38:
Chr22:29603355
NF2not providedBenign
(Jan 6, 2019)
criteria provided, single submitterVCV001265938
6.
GRCh37:
Chr22:29999358
GRCh38:
Chr22:29603369
NF2not providedLikely benign
(Apr 24, 2019)
criteria provided, single submitterVCV001212818
7.
GRCh37:
Chr22:29999413
GRCh38:
Chr22:29603424
NF2not providedLikely benign
(Jun 19, 2018)
criteria provided, single submitterVCV000674066
8.
GRCh37:
Chr22:29999586
GRCh38:
Chr22:29603597
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitterVCV000341058
9.
GRCh37:
Chr22:29999591
GRCh38:
Chr22:29603602
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitterVCV000341059
10.
GRCh37:
Chr22:29999668
GRCh38:
Chr22:29603679
NF2Neurofibromatosis, type 2Uncertain significance
(Jun 14, 2016)
criteria provided, single submitterVCV000341060
11.
GRCh37:
Chr22:29999704
GRCh38:
Chr22:29603715
NF2Neurofibromatosis, type 2Uncertain significance
(Jun 14, 2016)
criteria provided, single submitterVCV000341061
12.
GRCh37:
Chr22:29999720
GRCh38:
Chr22:29603731
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitterVCV000341062
13.
GRCh37:
Chr22:29999742
GRCh38:
Chr22:29603753
NF2Neurofibromatosis, type 2Benign
(Jan 13, 2018)
criteria provided, single submitterVCV000341063
14.
GRCh37:
Chr22:29999743
GRCh38:
Chr22:29603754
NF2Neurofibromatosis, type 2Benign
(Jan 13, 2018)
criteria provided, single submitterVCV000341064
15.
GRCh37:
Chr22:29999784
GRCh38:
Chr22:29603795
NF2Neurofibromatosis, type 2, not providedBenign
(Jun 19, 2018)
criteria provided, multiple submitters, no conflictsVCV000341065
16.
GRCh37:
Chr22:29999825
GRCh38:
Chr22:29603836
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitterVCV000901363
17.
GRCh37:
Chr22:29999843
GRCh38:
Chr22:29603854
NF2Neurofibromatosis, type 2Uncertain significance
(Jul 2, 2018)
criteria provided, single submitterVCV000584996
18.
GRCh37:
Chr22:29999878
GRCh38:
Chr22:29603889
NF2Neurofibromatosis, type 2, not providedBenign
(Jun 24, 2018)
criteria provided, multiple submitters, no conflictsVCV000341066
19.
GRCh37:
Chr22:29999970
GRCh38:
Chr22:29603981
NF2Neurofibromatosis, type 2, not specifiedBenign/Likely benign
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000262991
20.
GRCh37:
Chr22:29999978-30000111
GRCh38:
Chr22:29603989-29604122
NF2Neurofibromatosis, type 2Pathogenic
(Jun 8, 2019)
criteria provided, single submitterVCV000661747
21.
GRCh37:
Chr22:29999978-30077600
GRCh38:
Chr22:29603989-29681611
NF2Neurofibromatosis, type 2Pathogenic
(Nov 27, 2018)
criteria provided, single submitterVCV000640993
22.
GRCh37:
Chr22:29999982-30000107
GRCh38:
Chr22:29603993-29604118
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 3, 2018)
criteria provided, single submitterVCV000527727
23.
GRCh37:
Chr22:29999985-29999996
GRCh38:
Chr22:29603996-29604007
NF2Neurofibromatosis, type 2Uncertain significance
(Sep 30, 2019)
criteria provided, single submitterVCV000566704
24.
GRCh37:
Chr22:29999988
GRCh38:
Chr22:29603999
NF2M1Vnot provided, Neurofibromatosis, type 2Uncertain significance
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000956856
25.
GRCh37:
Chr22:29999989
GRCh38:
Chr22:29604000
NF2M1Tnot providedLikely pathogenic
(Mar 5, 2018)
criteria provided, single submitterVCV000504454
26.
GRCh37:
Chr22:29999991
GRCh38:
Chr22:29604002
NF2A2SSchwannomatosis 1, Meningioma, familial, Neurofibromatosis, type 2
Uncertain significance
(Apr 27, 2019)
criteria provided, single submitterVCV000638486
27.
GRCh37:
Chr22:29999993
GRCh38:
Chr22:29604004
NF2Neurofibromatosis, type 2Likely benign
(Jun 5, 2019)
criteria provided, single submitterVCV001085863
28.
GRCh37:
Chr22:29999994
GRCh38:
Chr22:29604005
NF2A4fsNeurofibromatosis, type 2Pathogenic
(Jul 19, 2019)
criteria provided, single submitterVCV000962511
29.
GRCh37:
Chr22:29999996
GRCh38:
Chr22:29604007
NF2Neurofibromatosis, type 2Likely benign
(Feb 28, 2019)
criteria provided, single submitterVCV001118453
30.
GRCh37:
Chr22:29999999-30000000
GRCh38:
Chr22:29604010-29604011
NF2I5VNeurofibromatosis, type 2Uncertain significance
(Mar 22, 2019)
criteria provided, single submitterVCV000968053
31.
GRCh37:
Chr22:29999999
GRCh38:
Chr22:29604010
NF2Hereditary cancer-predisposing syndrome, not specified, not provided,
Neurofibromatosis, type 2
Benign/Likely benign
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000237616
32.
GRCh37:
Chr22:30000002
GRCh38:
Chr22:29604013
NF2I5MNeurofibromatosis, type 2Uncertain significance
(Sep 13, 2019)
criteria provided, single submitterVCV000643742
33.
GRCh37:
Chr22:30000003
GRCh38:
Chr22:29604014
NF2A6PHereditary cancer-predisposing syndromeUncertain significance
(Aug 2, 2018)
criteria provided, single submitterVCV000819873
34.
GRCh37:
Chr22:30000004
GRCh38:
Chr22:29604015
NF2A6DNeurofibromatosis, type 2Uncertain significance
(Apr 17, 2019)
criteria provided, single submitterVCV000950781
35.
GRCh37:
Chr22:30000009
GRCh38:
Chr22:29604020
NF2R8CNeurofibromatosis, type 2Uncertain significance
(Aug 26, 2020)
criteria provided, single submitterVCV001036118
36.
GRCh37:
Chr22:30000012
GRCh38:
Chr22:29604023
NF2M9VHereditary cancer-predisposing syndromeUncertain significance
(Jun 1, 2018)
criteria provided, single submitterVCV000821551
37.
GRCh37:
Chr22:30000017
GRCh38:
Chr22:29604028
NF2F11fsnot providedPathogenic
(Feb 4, 2019)
criteria provided, single submitterVCV000818007
38.
GRCh37:
Chr22:30000019
GRCh38:
Chr22:29604030
NF2F11CNeurofibromatosis, type 2Uncertain significance
(Sep 20, 2020)
criteria provided, single submitterVCV001034701
39.
GRCh37:
Chr22:30000023
GRCh38:
Chr22:29604034
NF2not provided, Neurofibromatosis, type 2Conflicting interpretations of pathogenicity
(Dec 3, 2021)
criteria provided, conflicting interpretationsVCV001157795
40.
GRCh37:
Chr22:30000023-30000024
GRCh38:
Chr22:29604034-29604035
NF2L14fsnot providedPathogenic
(Aug 1, 2019)
criteria provided, single submitterVCV000870693
41.
GRCh37:
Chr22:30000030
GRCh38:
Chr22:29604041
NF2K15*Neurofibromatosis, type 2Pathogenic
(Oct 13, 2014)
no assertion criteria providedVCV000492891
42.
GRCh37:
Chr22:30000035
GRCh38:
Chr22:29604046
NF2Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Likely benign
(Nov 28, 2020)
criteria provided, multiple submitters, no conflictsVCV000457918
43.
GRCh37:
Chr22:30000037
GRCh38:
Chr22:29604048
NF2K17RNeurofibromatosis, type 2Uncertain significance
(Jun 22, 2020)
criteria provided, single submitterVCV001056444
44.
GRCh37:
Chr22:30000043
GRCh38:
Chr22:29604054
NF2P19RHereditary cancer-predisposing syndromeUncertain significance
(Aug 13, 2018)
criteria provided, single submitterVCV000825907
45.
GRCh37:
Chr22:30000044
GRCh38:
Chr22:29604055
NF2Neurofibromatosis, type 2Likely benign
(Sep 10, 2020)
criteria provided, single submitterVCV001078598
46.
GRCh37:
Chr22:30000045
GRCh38:
Chr22:29604056
NF2K20*Neurofibromatosis, type 2Pathogenic
(Jun 16, 2019)
criteria provided, single submitterVCV000938925
47.
GRCh37:
Chr22:30000045
GRCh38:
Chr22:29604056
NF2K20QNeurofibromatosis, type 2Uncertain significance
(Dec 26, 2019)
criteria provided, single submitterVCV000838853
48.
GRCh37:
Chr22:30000045-30000048
GRCh38:
Chr22:29604056-29604059
NF2K20fsNeurofibromatosis, type 2Likely pathogenic
(Nov 1, 2016)
criteria provided, single submitterVCV000547703
49.
GRCh37:
Chr22:30000054
GRCh38:
Chr22:29604065
NF2T23PNeurofibromatosis, type 2Uncertain significance
(May 20, 2020)
criteria provided, single submitterVCV001035608
50.
GRCh37:
Chr22:30000054-30000055
GRCh38:
Chr22:29604065-29604066
NF2V24fsNeurofibromatosis, type 2Pathogenic
(Jul 10, 2018)
criteria provided, single submitterVCV000644553
51.
GRCh37:
Chr22:30000056
GRCh38:
Chr22:29604067
NF2Neurofibromatosis, type 2Likely benign
(Jan 18, 2020)
criteria provided, single submitterVCV001134875
52.
GRCh37:
Chr22:30000056
GRCh38:
Chr22:29604067
NF2Neurofibromatosis, type 2Uncertain significance
(May 29, 2020)
criteria provided, single submitterVCV000964500
53.
GRCh37:
Chr22:30000058
GRCh38:
Chr22:29604069
NF2V24AHereditary cancer-predisposing syndromeUncertain significance
(Mar 25, 2019)
criteria provided, single submitterVCV000826903
54.
GRCh37:
Chr22:30000059
GRCh38:
Chr22:29604070
NF2Neurofibromatosis, type 2Likely benign
(Feb 21, 2020)
criteria provided, single submitterVCV001104143
55.
GRCh37:
Chr22:30000059
GRCh38:
Chr22:29604070
NF2not provided, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2
Likely benign
(Jan 17, 2020)
criteria provided, multiple submitters, no conflictsVCV000719886
56.
GRCh37:
Chr22:30000060
GRCh38:
Chr22:29604071
NF2R25GNeurofibromatosis, type 2Uncertain significance
(Mar 2, 2020)
criteria provided, single submitterVCV001057999
57.
GRCh37:
Chr22:30000060
GRCh38:
Chr22:29604071
NF2R25WNeurofibromatosis, type 2Uncertain significance
(May 30, 2019)
criteria provided, single submitterVCV000839589
58.
GRCh37:
Chr22:30000061
GRCh38:
Chr22:29604072
NF2R25KHereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Uncertain significance
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000580062
59.
GRCh37:
Chr22:30000064
GRCh38:
Chr22:29604075
NF2I26Tnot providedUncertain significance
(Sep 6, 2016)
criteria provided, single submitterVCV000422184
60.
GRCh37:
Chr22:30000065
GRCh38:
Chr22:29604076
NF2Neurofibromatosis, type 2Likely benign
(Feb 3, 2020)
criteria provided, single submitterVCV001113514
61.
GRCh37:
Chr22:30000065
GRCh38:
Chr22:29604076
NF2I26MNeurofibromatosis, type 2Uncertain significance
(May 2, 2019)
criteria provided, single submitterVCV000851328
62.
GRCh37:
Chr22:30000071
GRCh38:
Chr22:29604082
NF2Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Likely benign
(Feb 4, 2020)
criteria provided, multiple submitters, no conflictsVCV000822515
63.
GRCh37:
Chr22:30000072
GRCh38:
Chr22:29604083
NF2M29VNeurofibromatosis, type 2Uncertain significance
(Dec 11, 2019)
criteria provided, single submitterVCV000848840
64.
GRCh37:
Chr22:30000075
GRCh38:
Chr22:29604086
NF2D30NHereditary cancer-predisposing syndromeUncertain significance
(Jun 29, 2018)
criteria provided, single submitterVCV000822807
65.
GRCh37:
Chr22:30000076
GRCh38:
Chr22:29604087
NF2D30GNeurofibromatosis, type 2Uncertain significance
(Aug 2, 2020)
criteria provided, single submitterVCV001061022
66.
GRCh37:
Chr22:30000080
GRCh38:
Chr22:29604091
NF2Neurofibromatosis, type 2Uncertain significance
(Oct 7, 2020)
criteria provided, single submitterVCV001011330
67.
GRCh37:
Chr22:30000080-30000097
GRCh38:
Chr22:29604091-29604108
NF2not providedUncertain significance
(Mar 1, 2020)
criteria provided, single submitterVCV000916183
68.
GRCh37:
Chr22:30000081
GRCh38:
Chr22:29604092
NF2E32KHereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Uncertain significance
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000823288
69.
GRCh37:
Chr22:30000087
GRCh38:
Chr22:29604098
NF2E34QNeurofibromatosis, type 2Uncertain significance
(Jun 21, 2020)
criteria provided, single submitterVCV001056223
70.
GRCh37:
Chr22:30000092
GRCh38:
Chr22:29604103
NF2Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Likely benign
(Sep 20, 2020)
criteria provided, multiple submitters, no conflictsVCV000818315
71.
GRCh37:
Chr22:30000094
GRCh38:
Chr22:29604105
NF2N36IHereditary cancer-predisposing syndromeUncertain significance
(Mar 11, 2019)
criteria provided, single submitterVCV000818351
72.
GRCh37:
Chr22:30000094
GRCh38:
Chr22:29604105
NF2N36Snot provided, Neurofibromatosis, type 2, Hereditary cancer-predisposing syndrome,
not specified
Conflicting interpretations of pathogenicity
(Nov 7, 2021)
criteria provided, conflicting interpretationsVCV000134892
73.
GRCh37:
Chr22:30000098
GRCh38:
Chr22:29604109
NF2Neurofibromatosis, type 2Uncertain significance
(Sep 15, 2017)
criteria provided, single submitterVCV000527705
74.
GRCh37:
Chr22:30000102
GRCh38:
Chr22:29604113
NF2Neurofibromatosis, type 2Likely pathogenic
(Sep 13, 2020)
criteria provided, single submitterVCV001068058
75.
GRCh37:
Chr22:30000105
GRCh38:
Chr22:29604116
NF2Neurofibromatosis, type 2Uncertain significance
(Jul 25, 2019)
criteria provided, single submitterVCV000943289
76.
GRCh37:
Chr22:30000105
GRCh38:
Chr22:29604116
NF2Neurofibromatosis, type 2Uncertain significance
(Jan 1, 2019)
criteria provided, single submitterVCV000847088
77.
GRCh37:
Chr22:30000107
GRCh38:
Chr22:29604118
NF2Neurofibromatosis, type 2Uncertain significance
(Aug 9, 2020)
criteria provided, single submitterVCV000945221
78.
GRCh37:
Chr22:30000107
GRCh38:
Chr22:29604118
NF2Neurofibromatosis, type 2Uncertain significance
(Dec 1, 2016)
criteria provided, single submitterVCV000412208
79.
GRCh37:
Chr22:30000108
GRCh38:
Chr22:29604119
NF2Neurofibromatosis, type 2Likely benign
(Jul 13, 2020)
criteria provided, single submitterVCV001082160
80.
GRCh37:
Chr22:30000121
GRCh38:
Chr22:29604132
NF2not specifiedLikely benign
(Dec 20, 2016)
criteria provided, single submitterVCV000391964
81.
GRCh37:
Chr22:30000435-30000436
GRCh38:
Chr22:29604446-29604447
NF2not providedBenign
(Feb 27, 2021)
criteria provided, single submitterVCV001221963
82.
GRCh37:
Chr22:30024617
GRCh38:
Chr22:29628628
NF2Neurofibromatosis, type 2Uncertain significanceno assertion criteria providedVCV001050057
83.
GRCh37:
Chr22:30032484
GRCh38:
Chr22:29636495
NF2not providedBenign
(Jun 14, 2018)
criteria provided, single submitterVCV000668833
84.
GRCh37:
Chr22:30032730-30035211
GRCh38:
Chr22:29636741-29639222
NF2Neurofibromatosis, type 2Pathogenic
(Aug 28, 2018)
criteria provided, single submitterVCV000665033
85.
GRCh37:
Chr22:30032730-30057338
GRCh38:
Chr22:29636741-29661349
NF2Neurofibromatosis, type 2Pathogenic
(May 20, 2018)
criteria provided, single submitterVCV000583523
86.
GRCh37:
Chr22:30032734
GRCh38:
Chr22:29636745
NF2Neurofibromatosis, type 2Likely benign
(Jan 22, 2020)
criteria provided, single submitterVCV001112646
87.
GRCh37:
Chr22:30032736
GRCh38:
Chr22:29636747
NF2Neurofibromatosis, type 2Likely benign
(Feb 8, 2019)
criteria provided, single submitterVCV001102753
88.
GRCh37:
Chr22:30032739
GRCh38:
Chr22:29636750
NF2Neurofibromatosis, type 2Likely pathogenic
(Feb 4, 2021)
criteria provided, single submitterVCV000997868
89.
GRCh37:
Chr22:30032740
GRCh38:
Chr22:29636751
NF2M39VNeurofibromatosis, type 2Uncertain significance
(Jan 13, 2020)
criteria provided, single submitterVCV000966633
90.
GRCh37:
Chr22:30032747
GRCh38:
Chr22:29636758
NF2W41*Neurofibromatosis, type 2, not providedPathogenic
(Nov 7, 2021)
criteria provided, multiple submitters, no conflictsVCV000449433
91.
GRCh37:
Chr22:30032750-30032751
GRCh38:
Chr22:29636761-29636762
NF2G43fsSchwannomatosis 1Pathogenic
(Jan 1, 1995)
no assertion criteria providedVCV000003299
92.
GRCh37:
Chr22:30032751
GRCh38:
Chr22:29636762
NF2Neurofibromatosis, type 2, not providedLikely benign
(Oct 28, 2020)
criteria provided, single submitterVCV000751421
93.
GRCh37:
Chr22:30032757
GRCh38:
Chr22:29636768
NF2Neurofibromatosis, type 2Likely benign
(Aug 9, 2020)
criteria provided, single submitterVCV000772087
94.
GRCh37:
Chr22:30032758
GRCh38:
Chr22:29636769
NF2D45NNeurofibromatosis, type 2Uncertain significance
(Feb 4, 2020)
criteria provided, single submitterVCV001016914
95.
GRCh37:
Chr22:30032760
GRCh38:
Chr22:29636771
NF2not provided, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2
Likely benign
(Aug 31, 2020)
criteria provided, multiple submitters, no conflictsVCV000700743
96.
GRCh37:
Chr22:30032767
GRCh38:
Chr22:29636778
NF2D48NNeurofibromatosis, type 2Uncertain significance
(Jan 11, 2019)
criteria provided, single submitterVCV000844896
97.
GRCh37:
Chr22:30032775
GRCh38:
Chr22:29636786
NF2Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 2Conflicting interpretations of pathogenicity
(Nov 7, 2021)
criteria provided, conflicting interpretationsVCV000819417
98.
GRCh37:
Chr22:30032779
GRCh38:
Chr22:29636790
NF2R52WNeurofibromatosis, type 2Uncertain significance
(Jun 30, 2020)
criteria provided, single submitterVCV000849398
99.
GRCh37:
Chr22:30032782
GRCh38:
Chr22:29636793
NF2T53ANeurofibromatosis, type 2Uncertain significance
(Aug 6, 2018)
criteria provided, single submitterVCV000647351
100.
GRCh37:
Chr22:30032787
GRCh38:
Chr22:29636798
NF2Neurofibromatosis, type 2Uncertain significance
(May 15, 2019)
criteria provided, single submitterVCV000952692
Format
Items per page
Sort by

Download:

Choose Destination
Support Center